These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8645788)

  • 1. Effect of rifabutin on the pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Gallicano K; Sahai J; Swick L; Seguin I; Pakuts A; Cameron DW
    Clin Infect Dis; 1995 Oct; 21(4):1008-11. PubMed ID: 8645788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.
    Sahai J; Gallicano K; Garber G; Pakuts A; Cameron W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):54-60. PubMed ID: 7648285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients.
    Borin MT; Chambers JH; Carel BJ; Freimuth WW; Aksentijevich S; Piergies AA
    Antiviral Res; 1997 Jun; 35(1):53-63. PubMed ID: 9224961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.
    Trapnell CB; Narang PK; Li R; Lavelle JP
    Ann Intern Med; 1996 Mar; 124(6):573-6. PubMed ID: 8597321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Pakuts A; Cameron DW
    J Infect Dis; 1994 May; 169(5):1103-7. PubMed ID: 8169401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus.
    Sahai J; Gallicano K; Garber G; Pakuts A; Hawley-Foss N; Huang L; McGilveray I; Cameron DW
    Clin Pharmacol Ther; 1992 Nov; 52(5):464-70. PubMed ID: 1424420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
    Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
    J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.
    Bergshoeff AS; Fraaij PL; Verweij C; van Rossum AM; Verweel G; Hartwig NG; de Groot R; Burger DM
    J Antimicrob Chemother; 2004 Dec; 54(6):1152-4. PubMed ID: 15537694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
    Marier JF; Dimarco M; Guilbaud R; Dodard C; Morelli G; Tippabhotla SK; Singla AK; Thudi NR; Monif T
    J Clin Pharmacol; 2007 Nov; 47(11):1381-9. PubMed ID: 17962426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine.
    Lee BL; Täuber MG; Sadler B; Goldstein D; Chambers HF
    Clin Pharmacol Ther; 1996 Jan; 59(1):14-21. PubMed ID: 8549029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC
    Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.
    Cañas E; Pachon J; Garcia-Pesquera F; Castillo JR; Viciana P; Cisneros JM; Jimenez-Mejias ME
    Antimicrob Agents Chemother; 1996 Jan; 40(1):230-3. PubMed ID: 8787912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.
    Hoetelmans RM; Burger DM; Meenhorst PL; Beijnen JH
    Clin Pharmacokinet; 1996 Apr; 30(4):314-27. PubMed ID: 8983861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.
    Aweeka FT; Rosenkranz SL; Segal Y; Coombs RW; Bardeguez A; Thevanayagam L; Lizak P; Aberg J; Watts DH;
    AIDS; 2006 Sep; 20(14):1833-41. PubMed ID: 16954724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy.
    Cressey TR; Leenasirimakul P; Jourdain G; Tawon Y; Sukrakanchana PO; Lallemant M
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):387-9. PubMed ID: 16810125
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
    Clin Pharmacol Ther; 2004 Dec; 76(6):579-87. PubMed ID: 15592329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
    JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
    Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.